Form 6-K TEVA PHARMACEUTICAL INDU For: Feb 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Teva Pharma (TEVA) Declares $0.34 Quarterly Dividend; 2.4% Yield
February 5, 2015 7:05 AM ESTTeva Pharma (NYSE: TEVA) declared a quarterly dividend of $0.34 per share, or $1.36 annualized.
The dividend will be payable on March 3, 2015, to stockholders of record on February 19, 2015, with an ex-dividend date of February 17, 2015.
The annual yield on the dividend is 2.4... More
Teva Pharma (TEVA) Reports In-Line Q4 EPS
February 5, 2015 7:05 AM ESTTeva Pharma (NYSE: TEVA) reported Q4 EPS of $1.31, in-line with the analyst estimate of $1.31. Revenue for the quarter came in at $5.17 billion versus the consensus estimate of $5.17 billion.
For earnings history and earnings-related data on Teva Pharma (TEVA) click here.
... More